Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
- September -
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
- 2020 -
2021
-
2022
-
2023
-
2024
-
2025
September 2020 - 41 products
IP
CI
Azithromycin Spirig HC 250 mg
4
6.19
16.00
10 %
Coated tablets: Azithromycinum 250 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Azithromycin Spirig HC 250 mg
6
9.29
26.50
10 %
Coated tablets: Azithromycinum 250 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
Azithromycin Spirig HC 500 mg
3
9.29
26.50
10 %
Coated tablets: Azithromycinum 500 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Bydureon BCise 2 mg
4
90.57
114.90
10 %
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Enerzair Breezhaler
150/50/160 μg
30
63.11
85.05
10 %
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Enerzair Breezhaler
150/50/160 μg
30
63.11
85.05
10 %
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Enerzair Breezhaler
150/50/160 μg
90
189.33
222.30
10 %
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/80 μg
30
32.28
51.50
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/160 μg
30
32.28
51.50
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/320 μg
30
32.28
51.50
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/80 μg
90
96.74
121.65
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/160 μg
90
96.74
121.65
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/320 μg
90
96.74
121.65
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Xospata 40 mg
84
15062.96
15762.40
10 %
Coated tablets: Gilteritinibum 40 mg
Astellas Pharma AG
A / SL
FB
G
L
IP
CI
Elmiron 100 mg
90
461.02
517.80
10 %
Capsules: Heparinoidum (natrii Pentosani Polysulfas) 100 mg
Curatis AG
B / SL
FB
G
IP
CI
Cystadrops 3.8 mg/ml
5 ml
PR
PR
k.A.
Eye drops: Mercaptaminum 3.8 mg/ml
Recordati AG
B
FB
G
IP
Methylthioniniumchlorid
Proveblue 5 mg/ml
5 x 2 ml
PR
PR
k.A.
Injection solution: Methylthioninii Chloridum 5 mg/ml
Grosse Apotheke Dr. G.
Bichsel AG
B
FB
G
IP
Methylthioniniumchlorid
Proveblue 5 mg/ml
5 x 10 ml
PR
PR
k.A.
Injection solution: Methylthioninii Chloridum 5 mg/ml
Grosse Apotheke Dr. G.
Bichsel AG
B
FB
G
IP
Defitelio 80 mg/ml
10
PR
PR
k.A.
Concentrate for infusion: Defibrotidum (Hergestellt aus Darmschleimhaut von Schweinen) 80 mg/ml
MEDA Pharmaceuticals
Switzerland GmbH
A
FB
G
IP
Pantoprazole-Acino i.v.
PR
PR
k.A.
Lyophilisate: Pantoprazolum 40 mg
Acino Pharma AG
B
FB
G
IP
Pantoprazole-Acino i.v.
10 x 1
PR
PR
k.A.
Lyophilisate: Pantoprazolum 40 mg
Acino Pharma AG
B
FB
G
IP
CM
Piperacillin/Tazobactam-
Teva 2.25 g
PR
PR
k.A.
Lyophilisate: 2 Active Agents
Teva Pharma AG
A
FB
G
IP
CM
Piperacillin/Tazobactam-
Teva 4.5 g
PR
PR
k.A.
Lyophilisate: 2 Active Agents
Teva Pharma AG
A
FB
G
IP
CM
Piperacillin/Tazobactam-
Teva 4.5 g
PR
PR
k.A.
Lyophilisate: 2 Active Agents
Teva Pharma AG
A
FB
G
IP
CM
Piperacillin/Tazobactam-
Teva 4.5 g
10
PR
PR
k.A.
Lyophilisate: 2 Active Agents
Teva Pharma AG
A
FB
G
IP
CI
CM
Amavita Xylo Plus
10 ml
PR
PR
k.A.
Nasal spray: 2 Active Agents
Amavita Health Care AG
D
FB
G
IP
CI
CM
Coop Vitality Xylo Plus
10 ml
PR
PR
k.A.
Nasal spray: 2 Active Agents
Coop Vitality Health
Care GmbH
D
FB
G
IP
CI
CM
Sun Store Xylo Plus
10 ml
PR
PR
k.A.
Nasal spray: 2 Active Agents
Sun Store Health Care AG
D
FB
G
CI
CM
Sanactiv Arnika
Ringelblumen Gel
110 g
PR
PR
k.A.
Gel: 2 Active Agents
Tentan AG
E
FB
G
IP
CI
Elmiron 100 mg
90
PR
PR
k.A.
Capsules: Heparinoidum (natrii Pentosani Polysulfas) 100 mg
Curatis AG
B
FB
G
CI
Adler Allergie
400
PR
PR
k.A.
Tablets: 6 Active Agents
Adler Pharma Helvetia AG
D
FB
G
CI
Adler Allergie
1000
PR
PR
k.A.
Tablets: 6 Active Agents
Adler Pharma Helvetia AG
D
FB
G
IP
CI
Dexlansoprazole-Acino 30 mg
14
PR
PR
k.A.
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 30 mg
Acino Pharma AG
B
FB
G
IP
CI
Dexlansoprazole-Acino 30 mg
28
PR
PR
k.A.
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 30 mg
Acino Pharma AG
B
FB
G
IP
CI
Dexlansoprazole-Acino 30 mg
98
PR
PR
k.A.
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 30 mg
Acino Pharma AG
B
FB
G
IP
Dexlansoprazole-Acino 60 mg
14
PR
PR
k.A.
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 60 mg
Acino Pharma AG
B
FB
G
IP
Dexlansoprazole-Acino 60 mg
28
PR
PR
k.A.
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 60 mg
Acino Pharma AG
B
FB
G
IP
Dexlansoprazole-Acino 60 mg
56
PR
PR
k.A.
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 60 mg
Acino Pharma AG
B
FB
G
IP
CI
Alopexy 5%
60 ml
PR
PR
k.A.
Lösung zur Anwendung auf der Haut: Minoxidilum
Pierre Fabre Pharma SA
D
FB
G
IP
CI
Alopexy 5%
3 x 60 ml
PR
PR
k.A.
Lösung zur Anwendung auf der Haut: Minoxidilum
Pierre Fabre Pharma SA
D
FB
G
CI
A
Cardiodoron neue Formel
50 ml
PR
PR
k.A.
Tropfen zum Einnehmen: 3 Active Agents
Weleda AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home